Navigation Links
Advanced Life Sciences Ticker Symbol Reverts Back to 'ADLS.OB'
Date:4/27/2011

from those discussed herein due to several factors including the success and timing of our clinical trials and our ability to obtain and maintain regulatory approval and labeling of our product candidates; our plans to develop and commercialize our product candidates; the loss of key scientific or management personnel; the size and growth of potential markets for our product candidates and our ability to serve those markets; regulatory developments in the U.S. and foreign countries; the rate and degree of market acceptance of any future products; the accuracy of our estimates regarding expenses, future revenues and capital requirements; our ability to obtain financing on terms acceptable to us; our ability to obtain and maintain intellectual property protection for our product candidates; the successful development of our sales and marketing capabilities; the success of competing drugs that become available; and the performance of third party collaborators and manufacturers.  These and additional risks and uncertainties are detailed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
4. Genta Initiates Phase 3 AGENDA Trial of Genasense(R) for Patients with Advanced Melanoma
5. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
6. Advanced Life Sciences Announces ALS-357 Granted FDA Orphan Drug Designation for Metastatic Melanoma
7. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
8. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
9. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
10. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
11. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)...   Cepheid (Nasdaq: CPHD ) today announced ... second quarter ended June 30, 2015 on Thursday, July ... The Company will host a management presentation at ... to discuss the results.  To access the live webcast, ... least 15 minutes before the scheduled start time to ...
(Date:7/6/2015)... 6, 2015  OncoSec Medical Inc. ("OncoSec") (NASDAQ: ... today announced the appointment of Joann V. Lofgren ... of Market Development, effective July 6, 2015. In this ... and executing on the company,s market and product development ... excited to welcome Joann to the OncoSec team and ...
(Date:7/5/2015)... 2015 Nihon University is pleased to ... Medical-Engineering Collaboration "Medicine Definitely Jumps Up with 8K" ... Tokyo, Japan . Many experts ... will present their achievements and future prospects on ... produced with 8K technology. (Documentation: ...
Breaking Medicine Technology:OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 2OncoSec Medical Appoints Joann V. Lofgren as Vice President of Market Development 3Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3
(Date:7/6/2015)... MD (PRWEB) , ... July 06, 2015 , ... Dr. ... and Washington, DC, area patients. Kybella is a non-surgical method to dissolve ... use of reducing moderate to severe fat deposits under the chin, commonly known as ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... Thanks to ... Health and Hospice received the Music & Memory Certification for hospice patients and adult ... power of music not only to patients but also to their families and volunteers. ...
(Date:7/5/2015)... ... ... Women's Excellence in Wellness, powered by Movestrong announces parent/child fitness ... towards families that want their children to stay active as well as spend time ... take place TUESDAYS at 4:30pm. Questions? Call 248-601-6683. Women’s Excellence in Wellness, powered ...
(Date:7/4/2015)... ... ... a real millionaire online can be more difficult. Millionairematchapp.com is a leading ... worries from meeting partners. Recently, the site announced they're publishing of a list ... responded with excitement. , “There's quite a few millionaire dating apps online, but ...
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project Developer of ... expertise from the North American Board of Certified Energy Practitioners (NABCEP®), and is ... respected and well established national certification organization for renewable energy professionals. Designation as ...
Breaking Medicine News(10 mins):Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 2Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 3Health News:Music & Memory Program Brings Joy and Excitement to Hospice Patients 4Health News:MillionaireMatchapp.com Publishes the Best Millionaire Dating App and Official Dating Site Reviews 2015 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3
... with lung disease symptoms remain undiagnosed, experts say , ... of chronic obstructive pulmonary disease (COPD), but less than half ... to national survey results released this week by the U.S. ... , COPD affects 20 percent of U.S. adults over age ...
... ... (FDA), will deliver the opening keynote address to more than 8,000 professionals from the biopharmaceutical ... , ... 2009 -- Dr. Margaret Hamburg, Commissioner of the US Food and Drug Administration (FDA), will ...
... ... line of disposable, recyclable and customizable bibs to help keep both children and adults looking ... Rye, NY. , ... Hills, NY (PRWEB) November 4, 2009 -- Andre Muller is a successful entrepreneur who ...
... LEE, N.J., Nov. 4 In order to ... with two rampant medical conditions, depression and obesity, ... new, over-the-counter supplement with the ability to address ... under TNC,s Simple Wellness brand, has clinically established ...
... Nov. 4 Today, St. Jude Children,s Research Hospital launched ... unprecedented union of celebrities, media, retail and corporate partners that ... your life, and give to those who are not." The ... outreach director for St. Jude. , For the first ...
... Global public relations leader Porter Novelli announced today ... Marketing & Media for best unbranded TV advertisement/campaign. ... of its Shire Pharmaceuticals client, on the public service ... collaboration with Attention-Deficit/Hyperactivity Disorder (ADHD) advocacy groups ADHD Coaches ...
Cached Medicine News:Health News:Americans Gaining Awareness of COPD: Survey 2Health News:FDA Commissioner Margaret Hamburg to Deliver Keynote Address at DIA 46th Annual Meeting, June 13-17, 2010 in Washington, DC , 2Health News:FDA Commissioner Margaret Hamburg to Deliver Keynote Address at DIA 46th Annual Meeting, June 13-17, 2010 in Washington, DC , 3Health News:BibsToGo.com Answers: How Can a Traditional Baby Product Help Corporate America Look Better? 2Health News:New Product Launch - SAFFRENE Delivers Impressive Mood Elevation and Weight-loss Benefits 2Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 2Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 3Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 4Health News:Stars of Film, Television, Sports and Music Join Marlo Thomas to Kick Off the 6th Annual Thanks and Giving(R) Campaign to Support St. Jude Children's Research Hospital(R) 5Health News:Porter Novelli Wins Gold from Medical Marketing & Media for Best Unbranded TV Ad 2
Lyphochek Hemostasis Control is a multi-analyte control to help monitor coagulation factor assays and selected thrombosis risk assays. Assayed values are available for most major instrumentation....
... Blind Performance Specimens are intended ... specimen handling and transportation guidelines, including ... Drug Testing Programs regulated by the ... Administration (SAMHSA), Health and Human Services ...
Liquichek Sedimentation Rate Control is a bilevel human whole blood based control designed to monitor both manual and automated methods for measuring erythrocyte sedimentation rates....
Liquichek Hematology Control (A) is an assayed hematology control for evaluating the performance of Abbott Cell-Dyn 1600, 1700, 3000, 3500 and 3700 analyzers with 5-part differential technology....
Medicine Products: